Quest Diagnostics Beats Estimates by a Penny
TSC Staff
01/29/01 - 06:45 PM EST
| Earnings Scorecard |
| Actual | Estimated* | Year-Ago |
| $0.59 | $0.58 | $0.22
|
 |
Quest Diagnostics (DGX), a provider of diagnostic testing, information and services, reported fourth-quarter earnings that beat Wall Street's slightly raised expectations by a penny.
For the fourth quarter ended Dec. 31, income before extraordinary items rose to $28.3 million, or 59 cents a diluted share, from $9.7 million, or 22 cents a share, in 1999. According to
First Call/Thomson Financial, analysts were expecting the company to earn 58 cents in the latest quarter.
Quest, which is based in Teterboro, N.J., said fourth-quarter revenue increased to $836 million from $815 million in the same period a year ago.
